Published in J Virol on September 01, 2001
Induction of the human papillomavirus type 31 late promoter requires differentiation but not DNA amplification. J Virol (2005) 1.06
Independent contributions of polyomavirus middle T and small T to the regulation of early and late gene expression and DNA replication. J Virol (2006) 0.91
Stimulation of DNA replication from the polyomavirus origin by PCAF and GCN5 acetyltransferases: acetylation of large T antigen. Mol Cell Biol (2002) 0.90
Role of middle T-small T in the lytic cycle of polyomavirus: control of the early-to-late transcriptional switch and viral DNA replication. J Virol (2001) 0.86
Inhibition of polyomavirus ori-dependent DNA replication by mSin3B. J Virol (2002) 0.77
Identification of a protein-binding site that mediates transcriptional response of the c-fos gene to serum factors. Cell (1986) 9.10
Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J Biol Chem (1995) 6.25
A protein factor, ASF, controls cell-specific alternative splicing of SV40 early pre-mRNA in vitro. Cell (1990) 5.92
Phosphorylation of polyoma T antigens. Cell (1979) 3.94
The c-ets proto-oncogenes encode transcription factors that cooperate with c-Fos and c-Jun for transcriptional activation. Nature (1990) 3.74
Attenuation in the control of SV40 gene expression. Cell (1982) 3.32
Variations in polyoma virus genotype in relation to tumor induction in mice. Characterization of wild type strains with widely differing tumor profiles. Am J Pathol (1987) 2.84
Growth-regulated expression of D-type cyclin genes in human diploid fibroblasts. Proc Natl Acad Sci U S A (1992) 2.43
Nuclear antisense RNA induces extensive adenosine modifications and nuclear retention of target transcripts. Proc Natl Acad Sci U S A (1997) 2.33
Virus-specific early RNA in 3T6 cells infected by a tsA mutant of polyoma virus. Virology (1978) 2.31
Activation of the polyomavirus enhancer by a murine activator protein 1 (AP1) homolog and two contiguous proteins. Proc Natl Acad Sci U S A (1988) 2.24
Polyoma virus--a study of wild-type, mutant and defective DNAs. Cold Spring Harb Symp Quant Biol (1975) 2.17
Characterisation of polyoma late mRNA leader sequences by molecular cloning and DNA sequence analysis. Nucleic Acids Res (1980) 1.99
PEA3 is a nuclear target for transcription activation by non-nuclear oncogenes. EMBO J (1989) 1.97
Analysis of polyoma virus nuclear RNA by mini-blot hybridization. Proc Natl Acad Sci U S A (1977) 1.86
5' termini of polyoma virus early region transcripts synthesized in vivo by wild-type virus and viable deletion mutants. J Mol Biol (1982) 1.82
Amplification in the leader sequence of late polyoma virus mRNAs. Cell (1979) 1.74
Polyoma virus giant RNAs contain tandem repeats of the nucleotide sequence of the entire viral genome. Proc Natl Acad Sci U S A (1978) 1.67
Fos family members induce cell cycle entry by activating cyclin D1. Mol Cell Biol (1998) 1.61
Sequences in the polyomavirus DNA regulatory region involved in viral DNA replication and early gene expression. J Virol (1985) 1.60
Topography of the three late mRNA's of polyoma virus which encode the virion proteins. J Virol (1980) 1.59
Characterization of late polyoma mRNA. J Virol (1974) 1.53
Location of sequences in polyomavirus DNA that are required for early gene expression in vivo and in vitro. Mol Cell Biol (1984) 1.49
Nucleotides in the polyomavirus enhancer that control viral transcription and DNA replication. Mol Cell Biol (1987) 1.48
SV40 early-to-late switch involves titration of cellular transcriptional repressors. Genes Dev (1993) 1.44
Determination of sequences at the capped 5' ends of polyoma virus early region transcripts synthesized in vivo and in vitro demonstrates an unusual microheterogeneity. J Mol Biol (1982) 1.39
Regulation of polyomavirus transcription by large tumor antigen. Proc Natl Acad Sci U S A (1984) 1.38
DNA sequences required for specific and efficient initiation of transcription at the polyoma virus early promoter. Mol Cell Biol (1982) 1.34
Kinetics and efficiency of polyadenylation of late polyomavirus nuclear RNA: generation of oligomeric polyadenylated RNAs and their processing into mRNA. Mol Cell Biol (1984) 1.32
Regulation of polyomavirus late promoter activity by viral early proteins. J Virol (1986) 1.26
Electron microscopic mapping of RNA transcribed from the late region of polyoma virus DNA. J Virol (1979) 1.22
The length but not the sequence of the polyoma virus late leader exon is important for both late RNA splicing and stability. Nucleic Acids Res (1987) 1.21
Polyomavirus early-late switch is not regulated at the level of transcription initiation and is associated with changes in RNA processing. Proc Natl Acad Sci U S A (1988) 1.21
RNA polymerases stall and/or prematurely terminate nearby both early and late promoters on polyomavirus DNA. J Mol Biol (1988) 1.19
The polyomavirus enhancer comprises multiple functional elements. J Virol (1988) 1.14
Replication-dependent transactivation of the polyomavirus late promoter. J Virol (1990) 1.10
Leader-to-leader splicing is required for efficient production and accumulation of polyomavirus late mRNAs. J Virol (1989) 1.09
Isolation and characterization of poly(A)-containing intranuclear polyoma-specific "giant" RNA'S. Nucleic Acids Res (1976) 1.07
PEA1 and PEA3 enhancer elements are primary components of the polyomavirus late transcription initiator element. J Virol (1991) 1.04
Polyoma virus early-late switch: regulation of late RNA accumulation by DNA replication. Proc Natl Acad Sci U S A (1993) 0.98
Regulation of polyoma virus early transcription in transformed cells by large T-antigen. Virology (1982) 0.95
Role of middle T-small T in the lytic cycle of polyomavirus: control of the early-to-late transcriptional switch and viral DNA replication. J Virol (2001) 0.86
Splice site selection in polyomavirus late pre-mRNA processing. J Virol (1994) 0.83
RNA footprint mapping of RNA polymerase II molecules stalled in the intergenic region of polyomavirus DNA. J Virol (1995) 0.82
Stalling by RNA polymerase II in the polyomavirus intergenic region is dependent on functional large T antigen. Virology (1992) 0.82
Mutation of large T-antigen-binding site A, but not site B or C, eliminates stalling by RNA polymerase II in the intergenic region of polyomavirus DNA. J Virol (1993) 0.80
RNA polymerase II pauses in vitro, but does not terminate, at discrete sites in promoter-proximal regions on polyomavirus transcription complexes. Virology (1991) 0.79
Cell cycle control of polyomavirus-induced transformation. J Virol (1993) 0.76
Localization of gene functions in polyoma virus DNA. Proc Natl Acad Sci U S A (1976) 4.38
The influence of the reading context upon the suppression of nonsense codons. 3. Cold Spring Harb Symp Quant Biol (1969) 1.11
Combination chemotherapy with or without s.c. IL-2 and IFN-alpha: results of a prospectively randomized trial of the Cooperative Advanced Malignant Melanoma Chemoimmunotherapy Group (ACIMM). Br J Cancer (2002) 0.97
Counting and cardinal understanding in children with Down syndrome and typically developing children. Downs Syndr Res Pract (2001) 0.85
Intracellular morphogenesis of bacteriophage T4. I. Gene dosage effects on early functions and tail fiber assembly. Virology (1984) 0.84
Expression of proto-oncogenes in normal and papovavirus-transformed or -infected rat fibroblasts. Virology (1985) 0.83
Pharmacokinetics of sarizotan after oral administration of single and repeat doses in healthy subjects. Int J Clin Pharmacol Ther (2007) 0.77
Cisplatin, gemcitabine, and treosulfan in relapsed stage IV cutaneous malignant melanoma patients. Br J Cancer (2007) 0.76
Endothelin antagonists: discovery of EMD 122946, a highly potent and orally active ETA selective antagonist. Bioorg Med Chem Lett (1998) 0.76
[Malignant lymphoma of the skin: update on diagnostics and therapy of primary cutaneous B-cell lymphoma]. Hautarzt (2011) 0.75
(Re-) constructing pre-linguistic interpersonal processes to promote language development in young children with deviant or delayed communication skills. Br J Educ Psychol (2000) 0.75
Unified enantioselective capillary chromatography on a Chirasil-DEX stationary phase. Advantages of column miniaturization. J Chromatogr A (1995) 0.75
Enantiomer separation by complexation SFC on immobilized Chirasil-nickel and Chirasil-zinc. J Biochem Biophys Methods (2000) 0.75